INDP
Indaptus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.09
−7.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 3.90x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 36.20x
- Price / sales
- —
- Price / cash flow
- -27.12x
Enterprise value
- Enterprise value
- $400.2M
- EV / sales
- —
- EV / EBITDA
- -25.90x
- EV / EBIT
- -27.09x
- Market cap
- $411.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026